Ignite Creation Date:
2025-12-24 @ 10:39 PM
Ignite Modification Date:
2025-12-25 @ 8:10 PM
Study NCT ID:
NCT04689035
Status:
COMPLETED
Last Update Posted:
2023-07-20
First Post:
2020-12-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability and Pharmacokinetics of AVLX-144
Sponsor:
Avilex Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-27
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-15
First Submit QC Date:
None
Study First Post Date:
2020-12-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-18
Last Update Post Date:
2023-07-20
Last Update Post Date Type:
ACTUAL